Trustees’ Annual Report for the period
From 01/01/2025 To
31/12/2025
Charity name: A Rare Cause Charity registration number: 1198461
Objectives and Activities
| SORP reference | ||
|---|---|---|
| Summary of the purposes of the charity as set out in its governing document |
Para 1.17 | The advancement of health or the saving of lives in relation to the global rare disease community, in particular by providing information and resources to raise knowledge and increase awareness (as set out in the charity'sgoverningdocument). |
| Summary of the main activities in relation to those purposes for the public benefit, in particular, the activities, projects or services identified in the accounts. |
Para 1.17 and 1.19 |
During the period the charity supported diagnostic and clinical service delivery for rare disease patients in South Africa under a service level agreement with Rare Diseases South Africa; received and began administering a major grant from Direct Relief for the LSD- Impact programme; and undertook advocacy, education and awareness-raising activity, including participation in international rare disease conferences and working groups and patient storytellingcontent. |
| Statement confirming whether the trustees have had regard to the guidance issued by the Charity Commission on public benefit |
Para 1.18 | The trustees confirm that they have had regard to the Charity Commission's general guidance on public benefit in exercising their powers and duties, and are satisfied that the charity's aims and activities deliver public benefit consistent with its objects. |
Additional information (optional) You may choose to include further statements where relevant about:
| SORP reference | ||
|---|---|---|
| Policy on grant making | Para 1.38 | Grants and programme funding are made to partner organisations delivering rare disease diagnostic and support services overseas, under written service level agreements, with outcomes reported back to the trustees. |
| Policy on social investment including program related investment |
Para 1.38 | Not applicable – the charity does not hold funds for social investment. |
| Contribution made by volunteers |
Para 1.38 | Two volunteers supported the charity's activities during the period, in addition to the trustees. |
|---|---|---|
| Other |
Achievements and Performance
----- Start of picture text -----
SORP reference
----- End of picture text -----
| Achievements and Performance | Achievements and Performance | Achievements and Performance |
|---|---|---|
| SORP reference | ||
| Summary of the main achievements of the charity, identifying the difference the charity’s work has made to the circumstances of its beneficiaries and any wider benefits to society as a whole. |
Para 1.20 | The charity secured and began administering a significant grant from Direct Relief in support of its Lysosomal Storage Disease (LSD)-Impact rare disease programme, and continued to fund diagnostic support delivered in South Africa through its partner, Rare Diseases South Africa. Trustees and representatives strengthened ARC's international standing through participation in the International Rare Diseases Consortium Assembly (IRDiRC), the International Working Group on Gaucher Disease and the International MPS Society meeting, and through webinars with Rare Disease International, the African Society for Laboratory Medicine and other partners. Work also began on a flagship African-focused Gaucher disease/iPSC research initiative, and the charity's public advocacy and patient- storytelling activity (including a documentary on MPS I) extended its reach as a credible voice on rare disease andglobal health equity. |
Additional information (optional) You may choose to include further statements where relevant about:
| Achievements against objectives set |
Para 1.41 | Diagnostic support in South Africa continued under the service level agreement with Rare Diseases South Africa, and the charity began work on developing the first African-derived iPSC models for Gaucher disease research, in collaboration with academic partners in the USA. |
|---|---|---|
| Performance of fundraising activities against objectives set |
Para 1.41 | The charity received a major grant from Direct Relief for the LSD-Impact programme and initiated a grant application to the Michael J. Fox Foundation to fund a two-year postdoctoral research role supporting the Gaucher/iPSC initiative. |
| Investment performance against objectives |
Para 1.41 | Not applicable – the charity does not hold an investment portfolio; funds are held as cash. |
Financial Review
----- Start of picture text -----
Review of the charity’s Para 1.21 Total income for the period was £25,372 (2024:
financial position at the end £120), principally a grant of £25,342 from
of the period Direct Relief together with £30 of donations.
Total spending was £2,007, including £552
spent on the charity's programme in South
Africa (of which £502 was paid as a grant to
Rare Diseases South Africa) and the balance on
administration, travel and banking costs. The
charity held cash funds of £23,485.49 at 31
December 2025 (2024: £120), all as
unrestricted funds.
Statement explaining the Para 1.22 The trustees aim to hold reserves sufficient to
policy for holding reserves cover the charity's core running costs and
stating why they are held committed programme spend, noting that the
majority of funds held at the year end are
earmarked for the LSD-Impact programme.
Amount of reserves held Para 1.22 Total cash held was £23,485.49 at the year end,
the majority of which is committed to the LSD-
Impact programme.
Reasons for holding zero Para 1.22 Not applicable – the charity held cash reserves
reserves at the year end.
Details of fund materially in Para 1.24 None.
deficit
Explanation of any Para 1.23 The trustees have no material uncertainties
uncertainties about the about the charity's ability to continue as a
charity continuing as a going going concern.
concern
----- End of picture text -----
| Additional information (optional) You may choose to include further statements |
Additional information (optional) You may choose to include further statements |
where relevant about: |
|---|---|---|
| The charity’s principal sources of funds (including any fundraising) |
Para 1.47 | The charity's funds are principally derived from grants from international foundations and NGOs (including Direct Relief) and from individual donations. |
| Investment policy and objectives including any social investment policy adopted |
Para 1.46 | The charity does not hold an investment portfolio. Funds not immediately required are held as cash with Wise Payments Ltd and, from 2026, CAF Bank. |
| A description of the principal risks facing the charity |
Para 1.46 | The principal risks identified by the trustees are: reliance on a small number of grant funders and the risk of funding not being renewed; foreign exchange and payment- transfer risk on funds sent to support overseas programmes; and the capacity of a small, wholly volunteer trustee board to manage growth in the charity's activities. |
Structure, Governance and Management
| Description of charity’s trusts: |
||
|---|---|---|
| Type of governing document (trust deed, royal charter) |
Para 1.25 | Constitution (Charitable Incorporated Organisation – Foundation model), registered with the Charity Commission on 31 March 2022. |
| How is the charity constituted? (e.g unincorporated association, CIO) |
Para 1.25 | A Rare Cause is constituted as a Charitable Incorporated Organisation (CIO) – Foundation model. |
| Trustee selection methods including details of any constitutional provisions e.g. election to post or name of any person or body entitled to appoint one or more trustees |
Para 1.25 | Trustees are appointed by the existing trustees in accordance with the charity's constitution. |
Additional information (optional) You may choose to include further statements where relevant about:
| Policies and procedures adopted for the induction and training of trustees |
Para 1.51 | During the year, the trustees developed, reviewed and formally adopted policies covering bullying and harassment, international financial controls, risk management, and safeguarding. These policies are intended to support appropriate governance, oversight, and protection of the charity, its beneficiaries, volunteers, and other stakeholders. |
|---|---|---|
| The charity’s organisational structure and any wider network with which the charity works |
Para 1.51 | The charity is governed by a board of trustees (four trustees during the period) and has no employees; day-to-day activity is carried out by trustees and volunteers. |
| Relationship with any related parties |
Para 1.51 | No related party transactions were identified during the period; grant recipients were not related parties to the charity. |
Reference and Administrative details
----- Start of picture text -----
Charity name A Rare Cause
Other name the charity uses ARC
Registered charity number 1198461
Charity’s principal address 6 The Green, Ilkley, LS29 7FF
----- End of picture text -----
Names of the charity trustees who manage the charity
----- Start of picture text -----
Nam
e of
pers
on
(or
body
Dates acted if not for whole )
Trustee name Office (if any)
year entitl
ed to
appo
int
trust
ee (if
any)
1 Prof Amaka Offiah Whole year
2 Dr Dumebi Oderinde Whole year
3 Tiffany Wong Whole year
4 Linda Ebosie From 18 June 2025
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
----- End of picture text -----
– Corporate trustees names of the directors at the date the report was approved Director name Not applicable – A Rare Cause is a Charitable Incorporated Organisation and does not have corporate trustees.
Name of trustees holding title to property belonging to the charity
----- Start of picture text -----
Trustee name Dates acted if not for whole year
Not applicable – no assets are
held in the names of individual
trustees.
----- End of picture text -----
Funds held as custodian trustees on behalf of others
| Description of the assets held in this capacity |
Not applicable – the charity does not act as custodian trustee for other charities. |
|---|---|
| Name and objects of the charity on whose behalf the assets are held and how this falls within the custodian charity’s objects |
|
| Details of arrangements for safe custody and segregation of such assets from the charity’s own assets |
Additional information (optional)
Names and addresses of advisers (Optional information)
----- Start of picture text -----
Type of Name Address
adviser
Bankers Wise Payments Ltd 1st Floor, Worship Square, 65 Clifton Street, London EC2A 4JE
Bankers CAF Bank Ltd (account opened 2026, after this reporting period)
Name of chief executive or names of senior staff members (Optional information)
None – the charity has no employees; activities are undertaken by trustees and volunteers.
----- End of picture text -----
Exemptions from disclosure
Reason for non-disclosure of key personnel details
Not applicable – no exemption from disclosure has been applied.
Other optional information
Further detail on the charity's activities and strategic priorities during the period is set out in the Trustees' Update Report (June 2026), available separately.
Declarations
The trustees declare that they have approved the trustees’ report above.
Signed on behalf of the charity’s trustees
----- Start of picture text -----
Signature(s)
Full name(s) Tiffany Wong
Position (eg Secretary
Secretary, Chair, etc)
Date
October 25 2026
----- End of picture text -----
A RARE CAUSE
Financial Statements For the year ended 31 December 2025
Registered number: 1198461
A RARE CAUSE CONTENTS FOR THE YEAR ENDED 31 DECEMBER 2025
| CONTENTS | |
|---|---|
| Legal and administrative information | Page 1 |
| Statement of financial activities | Page 2 |
| Balance sheet | Page 3 |
A RARE CAUSE LEGAL AND ADMINISTRATIVE INFORMATION FOR THE YEAR ENDED 31 DECEMBER 2025
Trustees
-
L. Ebosie
-
A. Offiah
-
D. Oderinde
-
T. Wong
Charity Registered Number - 1198461
Registered Office
6 The Green Burley In Wharfedale Ilkley West Yorkshire LS29 7FF
Accountants
Bloomfield’s Bloomfield Court 76 Factory Street West Atherton, Manchester M46 0EF
1
A RARE CAUSE STATEMENT OF FINANCIAL ACTIVITIES AND BALANCE SHEET FOR THE YEAR ENDED 31 DECEMBER 2025
| Restricted funds Unrestricted funds 2025 2025 £ £ INCOMING RESOURCES Grants received 25,342 - Transfers from/to Deferred Income (22,965) - 2,377 - Fundraising - - Donations 30 - TOTAL INCOMING RESOURCES 2,407 - RESOURCES EXPENDED Direct Charitable Expenditure Travel 1,499 - Bank Charges 6 - Grants Made 502 - Accountancy & Secretarial 400 - TOTAL RESOURCES EXPENDED 2,407 - NET INCOMING / (OUTGOING) RESOURCES BEFORE TAXATION - - Taxation - - NET MOVEMENT IN FUNDS - - Fund balances at 1 April 2024 120 - FUND BALANCES AT 31 March 2025 120 - |
Total funds 2025 £ 25,342 (22,965) 2,377 - 30 2,407 1,499 6 502 400 2,407 - - - 120 120 |
Total funds 2024 £ - - - - 120 |
|---|---|---|
| 120 | ||
| - - - - - 120 - 120 |
||
| - | ||
| 120 |
2
A RARE CAUSE STATEMENT OF FINANCIAL ACTIVITIES AND BALANCE SHEET FOR THE YEAR ENDED 31 DECEMBER 2025
| CURRENT ASSETS Cash and bank in hand CREDITORS: Amounts falling due within one year Net current assets TOTAL ASSETS LESS CURRENT LIABILITIES NET ASSETS CHARITY FUNDS Restricted funds Unrestricted funds |
2025 £ 23,485 23,485 (23,365) 120 120 |
2024 £ £ 120 120 - 120 120 120 120 - 120 |
£ 120 120 - 120 |
|
|---|---|---|---|---|
The directors and trustees consider that the company is entitled to exemption from the requirement to have an audit under the provisions of S.480 of the Companies Act 2006.
No notice from the members under S.476 of the Companies Act 2006 requiring the company to have an audit has been deposited with the company.
The directors and trustees acknowledge their responsibility for ensuring that the company keeps accounting records which comply with S.386 of the Companies Act 2006, and for preparing accounts, which give a true and fair view of the state of the affairs of the company at 31[st ] December 2025 and of its net expenditure for the year then ended in accordance with the requirements of S.396, but which otherwise comply with the requirements of the Act relating to the accounts so far as applicable to the company.
The financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.
These financial statements were approved by the Trustees on 2026 and signed on their behalf, by: October 25,
Director
Date______2026 October 25,
3
6 The Green Ilkley LS29 7FF United Kingdom Registered charity in England & Wales Registration: 1198461
Charity commission
We believe independent auditors report is not required due to income level but audited accounts are attached and signed by trustee representative.
KR
Christian Hendriksz (Prof) Chief Community Impact Officer